Cytomos Company
Cytomos® develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains. Built upon our patented Cytomos® Dielectric Spectroscopy (CDS™) technology, our systems are unbiased, have single-cell resolution and are scalable across all upstream production stages. Leveraging the unmatched data depth per cell provided by CDS™, our proprietary machine learning (ML) algorithms provide insights into your bioprocesses like never before.
Investors
Technology:
Predictive Toxicology and ADMET Modeling
Industry:
BioPharma AI
Founded Date:
2011-01-01 00:00:00
Headquarters:
Edinburgh,Edinburgh, City of,United Kingdom,Europe
Funding Status:
private